Knott David M Jr - Q1 2022 holdings

$314 Million is the total value of Knott David M Jr's 180 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was - .

 Value Shares↓ Weighting
NewApollo Global Management, Inc.$15,498,000250,000
+100.0%
4.94%
VXX NewIpath Series B S&P 500 Short Term Future$6,425,000250,000
+100.0%
2.05%
BIP NewBrookfield Infrastructure Partners$2,980,00045,000
+100.0%
0.95%
BBIO NewBridgebio Pharma, Inc.$2,039,000200,893
+100.0%
0.65%
SRRA NewSierra Oncology$1,787,00055,758
+100.0%
0.57%
RDUS NewRadius Health Inc.$1,574,000178,218
+100.0%
0.50%
AUPH NewAurinia Pharmaceuticals Inc.$999,00080,694
+100.0%
0.32%
PCYO NewPurecycle Corp$962,00080,000
+100.0%
0.31%
BHVN NewBiohaven Pharmaceutical Holding Co. Ltd$931,0007,851
+100.0%
0.30%
CCOI NewCogent Communications Holdings$929,00014,000
+100.0%
0.30%
HVBC NewHV Bancorp$543,00025,000
+100.0%
0.17%
NewQualTek Services Inc. WTS$288,00025,000
+100.0%
0.09%
MGTX NewMeiraGTx Holding plc$277,00020,000
+100.0%
0.09%
RY NewRoyal Bank Canada$276,0002,500
+100.0%
0.09%
MTB NewM&T Bancorp$203,0001,199
+100.0%
0.06%
LW NewLamb West Holdings Inc.$200,0003,333
+100.0%
0.06%
IVV NewIshares Core S&P ETF S&P 500 index$195,000429
+100.0%
0.06%
NEM NewNewmont Corporation$159,0002,000
+100.0%
0.05%
NWBI NewNorthwest Bancshares Inc.$135,00010,000
+100.0%
0.04%
SPY NewSPDR S&P 500 ETF$113,000250
+100.0%
0.04%
ETTX NewEntasis Therapeutics Holding$78,00041,700
+100.0%
0.02%
TGNA NewTegna Inc.$67,0003,000
+100.0%
0.02%
LPTX NewLeap Therapeutics, Inc.$44,00025,100
+100.0%
0.01%
MIC NewMacquire Infrastructure Corp$39,00010,350
+100.0%
0.01%
NewGeneral Electric$29,000312
+100.0%
0.01%
IJR NewIshares Core S&P ETF Small Cap$21,000197
+100.0%
0.01%
RSP NewInvesco Trust ETF S&P 500 Equal Weight RSP$15,00096
+100.0%
0.01%
GM NewGeneral Motors$12,000275
+100.0%
0.00%
VNQ NewVanguard Index Real Estate$8,00074
+100.0%
0.00%
RPV NewInvesco Trust ETF S&P 500 Equal Weight pure Value$7,00078
+100.0%
0.00%
PG NewProctor & Gamble$5,00035
+100.0%
0.00%
ABT NewAbbott Labs$6,00050
+100.0%
0.00%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Calumet Specialty Products Partners, LP8Q3 202331.5%
Alphabet Inc-Cl C8Q3 20235.6%
DocGo, Inc.8Q3 20235.8%
Ligand Pharmaceuticals Incorporated8Q3 20234.3%
Franklin BSP Realty Trust, Inc.8Q3 20234.9%
Midwest Holding Inc.8Q3 20234.1%
Coliseum Acquisition Corp.WTS8Q3 20232.4%
Pfizer Inc.8Q3 20233.2%
Jazz Pharmaceuticals PLC8Q3 20231.5%
Vertex Pharmaceuticals, Inc.8Q3 20232.1%

View Knott David M Jr's complete holdings history.

Latest significant ownerships (13-D/G)
Knott David M Jr Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Calumet Specialty Products Partners, L.P.November 08, 20214,292,2005.4%

View Knott David M Jr's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-13
42023-12-22
SC 13D/A2023-12-22
13F-HR2023-11-13
13F-HR2023-08-11
13F-HR2023-05-11
13F-HR2023-02-13
13F-HR2022-11-10
42022-09-26
42022-09-02

View Knott David M Jr's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (313946000.0 != 313961000.0)

Export Knott David M Jr's holdings